338 related articles for article (PubMed ID: 32592910)
1. Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
Nakayama T; Nozawa N; Kawada C; Yamamoto S; Ishii T; Ishizuka M; Namikawa T; Ogura SI; Hanazaki K; Inoue K; Karashima T
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101893. PubMed ID: 32592910
[TBL] [Abstract][Full Text] [Related]
2. Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cancer cell-line model.
French AJ; Datta SN; Allman R; Matthews PN
BJU Int; 2004 Jan; 93(1):156-61. PubMed ID: 14678389
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
4. Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
Nakayama T; Otsuka S; Kobayashi T; Okajima H; Matsumoto K; Hagiya Y; Inoue K; Shuin T; Nakajima M; Tanaka T; Ogura SI
Sci Rep; 2016 Nov; 6():36478. PubMed ID: 27857072
[TBL] [Abstract][Full Text] [Related]
5. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
6. C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres.
Park J; Oh SJ; Shim JK; Ji YB; Moon JH; Kim EH; Huh YM; Suh JS; Chang JH; Lee SJ; Kang SG
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4391-4402. PubMed ID: 36107247
[TBL] [Abstract][Full Text] [Related]
7. Optimization of 5-aminolevulinic acid-based photodynamic therapy protocol for breast cancer cells.
Guney Eskiler G; Deveci Ozkan A; Sozen Kucukkara E; Kamanlı AF; Gunoğlu B; Yıldız MZ
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101854. PubMed ID: 32512246
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
Ziegler VG; Knaup J; Stahl D; Krammer B; Plaetzer K
Lasers Surg Med; 2011 Sep; 43(7):548-56. PubMed ID: 22057482
[TBL] [Abstract][Full Text] [Related]
9. Cell senescence-associated porphyrin metabolism affects the efficacy of aminolevulinic acid-photodynamic diagnosis in bladder cancer.
Lai HW; Yamamoto S; Fukuhara H; Ogura SI; Inoue K
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103581. PubMed ID: 37116819
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
11. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
[TBL] [Abstract][Full Text] [Related]
12. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
13. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
14. Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells.
Omura N; Nonoguchi N; Fujishiro T; Park Y; Ikeda N; Kajimoto Y; Hosomi R; Yagi R; Hiramatsu R; Furuse M; Kawabata S; Fukunaga K; Kuroiwa T; Nakano I; Wanibuchi M
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103119. PubMed ID: 36336324
[TBL] [Abstract][Full Text] [Related]
15. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
[TBL] [Abstract][Full Text] [Related]
16. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
20. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
